Table 2.
Technical feasibility and safety for all cysts
| Cyst access [n (%)] | |
| Easy | 188 (91) |
| Moderate or difficult | 18 (9) |
| Needle type [n (%)] | |
| 19 G Echo Tip Ultra* | 21 (10) |
| 19 G Expect Flexible† | 185 (90) |
| Access route [n (%)] | |
| Transgastric | 140 (68) |
| Transduodenal | 66 (32) |
| Second part of the duodenum | 5 (2) |
| Miniprobe extraction from the needle [n (%)] | |
| Possible | 195 (95) |
| Not possible (extracted together with the needle) | 11 (5) |
| Cytohistology [n (%)] | |
| Contributive | 61 (30) |
| Non-contributive | 145 (70) |
| Biochemical dosage [n (%)] | |
| Successful | 157 (76) |
| Unsuccessful | 49 (24) |
| Insufficient fluid volume | 34 (17) |
| Intracystic bleeding (hematic fluid) | 8 (4) |
| High viscosity | 4 (1.9) |
| Fluid leak | 3 (1.4) |
| Safety [n (%)] | |
| Post-procedure pancreatitis | 3 (1.4) |
nCLE needle-based confocal laser endomicroscopy
*Cook Medical Inc., Bloomington, Indiana, USA
†Boston Scientific Corp., Marlborough, Massachusetts, USA